We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -4.88% | 4.875 | 4.75 | 5.00 | 5.125 | 4.875 | 5.13 | 630,501 | 14:14:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -1.09 | 5.61M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/3/2021 07:57 | Ok, amaretto officially filtered now for being more dense than Earth's inner core!!!! | k1ngkonggb | |
09/3/2021 07:54 | Massive shorts building !! | amaretto1 | |
09/3/2021 07:45 | many thanks BV, i wonder why was this not disclosed in RNS for the benefit of the inerudite? ;) the contracts begin to roll in , should see a good reaction in share price today. | stoxx67 | |
09/3/2021 07:41 | According to Genedrive the US military is worth 10 million a year. | blackvulture | |
09/3/2021 07:40 | Your being foooked over !!Big time | amaretto1 | |
09/3/2021 07:39 | Just one ? | amaretto1 | |
09/3/2021 07:37 | Any sales ??? | amaretto1 | |
09/3/2021 07:35 | That is because Amaretto is one of the many thick people on the planet with internet access, and we all know what state the world is in! | boysie72 | |
09/3/2021 07:29 | Is there anything these guys can't test for? Maybe they should develop an 'Intelligent Lifeform Test (ILT)'......oh, I didn't realise. This test is already available! Dear Amaretto, Your ILT results are as follows: FAIL Retest result: FAIL If you need help reading this letter or interpreting the result, please call Gamblers Anonymous! | hodhasharon | |
09/3/2021 07:28 | Why spend your time doing this amaretto? Do you not have a family ? Honestly you should look in the mirror and think about your life | jock3636 | |
09/3/2021 07:26 | Any sales Have they sold 1 yet ? | amaretto1 | |
09/3/2021 07:24 | GDR has done a Beckman Coulter with Mountain Horse Solutions for the military: genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has entered into an agreement for the distribution of the Company's military pathogen detection assays in the United States with Mountain Horse Solutions ("Mountain Horse"), a military contracting specialist to U.S. Federal, State, and Local Government customers. genedrive has a unique product with regard to military CBRNE(1) requirements. The Genedrive(R) BioPlex range of products was developed to the U.S. Department of Defense's (U.S. DoD) product specification with the help of U.S. DoD funding. Designed for field portability and rapid determination of biothreats from pathogens, the Genedrive BioPlex system was developed over a period of five years and has been approved to deployment stage. Contracting with the U.S. Government can be challenging and time consuming. The Company believes that establishing new, local representation in the United States with identified contacts in this highly specialised field will help drive broader product uptake. Organisations like Mountain Horse are already contracted with the U.S. Government, which includes existing framework purchasing agreements, providing an opportunity for more rapid order placement and replenishment of products without the need for new contracts to be negotiated. Bill Allen, President of Mountain Horse Solutions, said: "We are delighted to be working with genedrive with these exciting pathogen detection products. The addition of genedrive's assays to our portfolio of CBRNE mission critical products provides a unique offering of combat-ready sampling and detection devices." David Budd, CEO of genedrive plc, said: "The agreement allows the supply of our BioPlex pathogen detection assays through Mountain Horse, a military contracting specialist who has a number of existing framework contracts with target clients such as the U.S. DoD. We believe that they have both the industry sector knowledge and existing commercial arrangements to increase the exposure of our products and gain new customer opportunities within the various branches and departments of the DoD and U.S. Government."> | aquilla | |
09/3/2021 07:19 | You know what! I can seriously see Genedrive as a multi-billion pound company. I'm talking £100 £200 £300 per share. | hodhasharon | |
09/3/2021 07:15 | Interesting opening today, implications for us military, how many soldiers that might be tested with this product and how often. | p winky | |
09/3/2021 07:12 | Dear Amaretto, We all all make mistakes. You sold too early and assumed the share price would drop back. It hasn't, and it won't. We are going to £10. Get back in soon if you can. | hodhasharon | |
09/3/2021 07:08 | Any sales ?? | amaretto1 | |
09/3/2021 07:07 | Us military contracts are highly lucrative with good ROI....no penny pinching | yet another final | |
08/3/2021 20:07 | Biden’s $1.9 trillion stimulus plan is a golden opportunity for British business Joe Biden’s consumer spending boom may end in tears, but the opportunities for UK plc across the pond could be huge Exports of medical products to the US are already worth more than £6bn a year, and life sciences are on fire in this country, in part because we have now freed ourselves from the EU’s over-bureaucratic, innovation-killing regulations. | mrshaungcm | |
08/3/2021 16:23 | Without doubt, I would rather sit next to a passenger who just passed a test, than someone with just a vaccine as their most recent precaution. The people protesting against passport related documents for Covid tests and vaccines is an idiot. A lot of public situations will require rapid testing though. | boysie72 | |
08/3/2021 15:44 | You go abroad they will want to see covid test, regardless you had vaccine. | neo26 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions